{"blog": [], "keywords": [{"value": "Drugs (Pharmaceuticals)", "name": "subject", "rank": "1", "is_major": "Y"}, {"value": "Food and Drug Administration", "name": "organizations", "rank": "2", "is_major": "Y"}, {"value": "Upton, Fred", "name": "persons", "rank": "3", "is_major": "N"}, {"value": "Regulation and Deregulation of Industry", "name": "subject", "rank": "4", "is_major": "N"}, {"value": "House of Representatives", "name": "organizations", "rank": "5", "is_major": "N"}], "web_url": "http://www.nytimes.com/2015/05/01/health/bill-to-speed-approvals-for-drugs-is-cut-back.html", "document_type": "article", "byline": {"person": [{"lastname": "TAVERNISE", "firstname": "Sabrina", "role": "reported", "organization": "", "rank": 1}], "original": "By SABRINA TAVERNISE"}, "type_of_material": "News", "multimedia": [], "section_name": "Health", "word_count": "663", "source": "The New York Times", "subsection_name": null, "lead_paragraph": "Legislation that would have accelerated the process in a way that critics said threatened to erode patient safety was formally released, in a scaled-back version with many of the most controversial provisions left out.", "pub_date": "2015-05-01T00:00:00Z", "news_desk": "National", "headline": {"print_headline": "Bill to Speed Approvals for Drugs Is Cut Back", "main": "Bill to Speed Approvals for Drugs Is Cut Back"}, "print_page": "16", "snippet": "Legislation that would have accelerated the process in a way that critics said threatened to erode patient safety was formally released, in a scaled-back version with many of the most controversial provisions left out.", "_id": "5542cc2b38f0d83d46e51ef0", "slideshow_credits": null, "abstract": "House releases scaled-back draft of bill intended to speed up pace at which Food and Drug Administration approves drugs; critics had charged that changes would impact public safety."}